PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 2026Alzheimer s & Dementia0 citations

Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic change

View Full Paper
MMMiller MDHWHeather J. WisteDJD H Johnson

Key Points

  • This study aims to evaluate the correlation between positive amyloid PET scans and the levels of Alzheimer's disease neuropathologic change (ADNC) at autopsy.
  • Participants with positive amyloid PET scans categorized by ADNC levels at autopsy.
  • Groups based on time from initial positive amyloid PET to death: <5 years, 5 to <10 years, and 10+ years.
  • 90% of participants with positive amyloid PET had intermediate/high ADNC at autopsy (234/259).
  • In the 10+ year group (n = 39), only 8% had not/low ADNC (3/39).

Abstract

INTRODUCTION: Alzheimer's disease neuropathologic change (ADNC) classification identifies not/low and intermediate/high levels of neuropathology. Our goal was to assess how frequently a positive amyloid positron emission tomography (PET) scan indicates not/low ADNC and whether this autopsy finding can occur >10 years after a positive amyloid PET. METHODS: Participants with positive amyloid PET scans were categorized by levels of ADNC at autopsy, grouped by time from initial positive amyloid PET to time of death (<5 years, 5 to <10 years, or 10+ years). RESULTS: Among those with a positive amyloid PET scan, the majority had intermediate/high ADNC at autopsy (234/259, 90%). In the group with 10+ years between a positive amyloid PET and death (n = 39) not/low ADNC occurred in 3/39 (8%). DISCUSSION: Not/low ADNC is uncommon among those with positive amyloid PET scans. After 10+ years, it is possible but rare for a positive amyloid PET scan to represent an indolent state of neuropathology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

MD et al. (2026) studied this question.

synapsesocial.com/papers/69fed021b9154b0b82877241https://doi.org/10.1002/alz.71449
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Association Between Positive Amyloid-PET and Cognitive Decline Is Not Always Supportive of Alzheimer’s Disease: Suggestions from a Case Report2024
  2. 2Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study2024 · 9 citations
  3. 3A probabilistic framework for clinicopathological Alzheimer’s disease using tau-PET2026
  4. 4Incremental value of amyloid PET in a tertiary memory clinic setting in China2024 · 4 citations
  5. 5Amyloid-PET imaging predicts functional decline in clinically normal individuals2024 · 1 citations